SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:lnu-26677"
 

Search: onr:"swepub:oai:DiVA.org:lnu-26677" > Antihypertensive dr...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Ekman, Elisabet,1953-Regional Pharmacovigilance Unit, Clinical Pharmacology, Lund University Hospital, Lund, Sweden (author)

Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers

  • Article/chapterEnglish2010

Publisher, publication year, extent ...

  • United States :Dove Medical Press Ltd,2010
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:lnu-26677
  • https://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-26677URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-54789URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • AIM: To describe spontaneously reported cases of erectile dysfunction (ED) in association with angiotensin II type I blockers (ARB) and other antihypertensive drugs.SUBJECTS AND METHODS: All spontaneously reported cases of ED submitted to the Swedish Medical Products Agency (MPA) between 1990 and 2006, where at least one antihypertensive drug was the suspected agent, were scrutinized. Patient demographics, drug treatment and adverse reactions were recorded. Using the Bayesian Confidence Propagation Neural Network (BCPNN) method, the information component (IC) was calculated.RESULTS: Among a total of 225 reports of ED, 59 involved antihypertensive drugs including ARB (9 cases) as suspected agents. A positive IC value was found indicating that ED was reported more often in association with antihypertensive drugs classes, except for angiotensin-converting enzyme inhibitors, compared with all other drugs in the database. Positive dechallenge was reported in 43 cases (72%).DISCUSSION: All classes of major antihypertensive drugs including ARB were implicated as suspected agents in cases of ED. Few risk factors were identified. The relatively high reporting of ED in association with ARB is in contrast with previous studies, suggesting that ARB have neither a positive nor any effect on ED. This discrepancy suggests that further studies are warrnted on this potential adverse reaction to ARB.

Subject headings and genre

  • erectile dysfunction
  • adverse drug reaction
  • spontaneous reporting
  • antihypertensive drugs
  • angiotensin II type 1 receptor blockers
  • Biomedical Sciences
  • Biomedicinsk vetenskap
  • MEDICINE

Added entries (persons, corporate bodies, meetings, titles ...)

  • Hägg, StaffanÖstergötlands Läns Landsting,Linköpings universitet,Klinisk farmakologi,Hälsouniversitetet(Swepub:liu)staha06 (author)
  • Sundström, AndersCentre for Pharmacoepidemiology, Karolinska Institute, Stockholm, Sweden (author)
  • Werkström, ViktoriaRegional Pharmacovigilance Unit, Clinical Pharmacology, Lund University Hospital, Lund, Sweden (author)
  • Regional Pharmacovigilance Unit, Clinical Pharmacology, Lund University Hospital, Lund, SwedenKlinisk farmakologi (creator_code:org_t)

Related titles

  • In:Drug, Healthcare and Patient SafetyUnited States : Dove Medical Press Ltd2, s. 21-251179-1365

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view